JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)

NCT06514768 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China